Page 116 - 南京医科大学自然版
P. 116

第44卷第10期
               ·1432 ·                           南 京    医 科 大 学 学         报                        2024年10月


             [参考文献]                                             [12]CHENG Y,BAI L,SHANG J,et al. Preliminary clinical
                                                                     results for PET/MR compared with PET/CT in patients
             [1] MESIA R,IGLESIAS L,LAMBEA J,et al. SEOM clinical
                                                                     with nasopharyngeal carcinoma[J]. Oncol Rep,2020,43
                   guidelines for the treatment of head and neck cancer
                                                                    (1):177-187
                  (2020)[J]. Clin Transl Oncol,2021,23(5):913-921
                                                                [13]FLYGARE L,ERDOGAN S T,SODERKVIST K. PET/
             [2] SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer
                                                                     MR versus PET/CT for locoregional staging of oropharyn⁃
                   statistics 2020:GLOBOCAN estimates of incidence and
                                                                     geal squamous cell cancer[J]. Acta Radiol,2023,64(5):
                   mortality worldwide for 36 cancers in 185 countries[J].
                                                                     1865-1872
                   CA Cancer J Clin,2021,71(3):209-249
                                                                [14]KUHN F P,HULLNER M,MADER C E,et al. Contrast⁃
             [3] JOHNSON D E,BURTNESS B,LEEMANS C R,et al.
                                                                     enhanced PET/MR imaging versus contrast ⁃ enhanced
                   Head and neck squamous cell carcinoma[J]. Nat Rev Dis
                                                                     PET/CT in head and neck cancer:how much MR informa⁃
                   Primers,2020,6(1):92
                                                                     tion is needed?[J]. J Nucl Med,2014,55(4):551-558
             [4] LINGL J P,BOHM F,SCHULER P J,et al. Value of PET
                                                                [15]KAO J,LAVAF A,TENG M S,et al. Adjuvant radiotherapy
                   imaging in head and neck cancer[J]. HNO,2023,71
                                                                     and survival for patients with node⁃positive head and neck
                  (10):681-692
                                                                     cancer:an analysis by primary site and nodal stage[J].
             [5] MENG Z,ZHANG L,HUANG C,et al. Quantitative pa⁃
                                                                     Int J Radiat Oncol Biol Phys,2008,71(2):362-370
                   rameters derived from(18)F⁃fluorodeoxyglucose positron
                                                                [16]ZHANG Y,YU J,ZHU H. Risk factors for cervical lymph
                   emission tomography/magnetic resonance imaging can ac⁃
                                                                     node metastasis of head and neck squamous cell carcino⁃
                   curately estimate the histologic grade of hypopharyngeal  ma:a retrospective population⁃based study[J]. J Stomatol
                   squamous cell carcinoma preoperatively[J]. Neuroradiolo⁃  Oral Maxillofac Surg,2022,123(5):e484-e488
                   gy,2022,64(11):2153-2162                     [17]ZHANG D,LI L. Risk factors and prognostic models of
             [6] CHEN Y,DANG H,WU X,et al. Correlation between(18)   lymph node metastatic hypopharyngeal squamous cell car⁃
                   F ⁃ FDG PET/MR parameters with the expression level of  cinoma[J]. Eur Arch Otorhinolaryngol,2023,280(11):
                   epidermal growth factor receptor and the diagnostic value  5019-5029
                   of PET/MR in head and neck squamous cell carcinoma[J].  [18]VAN STAALDUINEN E K,MATTHEWS R,KHAN A,et
                   Heliyon,2023,9(4):e14822                          al. Improved cervical lymph node characterization among
             [7] ZHANG L,MENG Z,HUANG C,et al. Combined average      patients with head and neck squamous cell carcinoma us⁃
                   standard uptake value and rate constant can predict ex⁃  ing MR texture analysis compared to traditional FDG ⁃
                   pression of EGFR in hypopharyngeal squamous cell carci⁃  PET/MR features alone[J]. Diagnostics,2024,14(1):71
                   noma:A pilot study with integrated PET/MRI[J]. Eur J  [19]CEBECI S,AYDOS U,YENICERI A,et al. Diagnostic
                   Radiol,2024,172:111326                            performance of FDG PET/MRI for cervical lymph node
             [8] GUZMAN P G,IVANIDZE J. PET/CT and PET/MR im⁃        metastasis in patients with clinically N0 head and neck
                   aging of the post ⁃ treatment head and neck:traps and  cancer[J]. Eur Rev Med Pharmacol Sci,2023,27(10):
                   tips[J]. Neuroimaging Clin N Am,2022,32(1):111-132  4528-4535
             [9] RUHLMANN V,RUHLMANN M,BELLENDORF A,et          [20]CHIESA⁃ESTOMBA C M,LECHIEN J R,AYAD T,et al.
                   al. Hybrid imaging for detection of carcinoma of unknown  Clinical and histopathological risk factors for distant me⁃
                   primary:a preliminary comparison trial of whole ⁃ body  tastasis in head and neck cancer patients[J]. Acta Otorhi⁃
                   PET/MRI versus PET/CT[J]. Eur J Radiol,2016,85    nolaryngol Ital,2021,41(1):6-17
                  (11):1941-1947                                [21]DUPREZ F,BERWOUTS D,DE NEVE W,et al. Distant
             [10]PARK J,PAK K,YUN T J,et al. Diagnostic accuracy and  metastases in head and neck cancer[J]. Head Neck,
                             18
                   confidence of F FDG PET/MRI in comparison with PET  2017,39(9):1733-1743
                   or MRI alone in head and neck cancer[J]. Sci Reports,  [22]MIRSHAHVALAD S A,KOHAN A,METSER U,et al.
                   2020,10(1):9490                                   Diagnostic performance of whole⁃body[(18)F]FDG PET/
             [11]HUANG C,SONG T,MUKHERJI S K,et al. Comparative      MR in cancer M staging:a systematic review and meta⁃
                   study between integrated positron emission tomography/  analysis[J]. Eur Radiol,2024,34(1):673-685
                   magnetic resonance and positron emission tomography/  [23]PIAO Y,CAO C,XU Y,et al. Detection and staging of re⁃
                   computed tomography in the T and N staging of hypopha⁃  current or metastatic nasopharyngeal carcinoma in the era
                   ryngeal cancer:an initial result[J]. J Comput Assist To⁃  of FDG PET/MR[J]. Eur Arch Otorhinolaryngol,2022,
                   mogr,2020,44(4):540-545                           279(1):353-359
   111   112   113   114   115   116   117   118   119   120   121